MLSPF
Melrose Industries PLC
Set alert
6.34 USD +0.34 +5.67%
6.05 Day range 6.05
5.71 52-week range 9.51
- YTD
- -17.77%
- 1 year
- -26.45%
- Open
- 6.05
- Prev close
- 6.00
- Mkt cap
- 7.90B
- Vol
- 300
- Avg vol
- 31.84K
- EPS
- 0.17
- P/E
- 37.29
More statistics
- Low
- 6.05
- High
- 6.05
- Earnings
- Mar 4, 2027
Next earnings
Mar 4, 2027
Expected Mar 4, 2027. Consensus EPS estimate 0.2731.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 4, 2027 | Dec 30, 2026 | 0.2731 | — | — | — |
| Jul 31, 2026 | Jun 30, 2026 | 0.2278 | 0.2346 | +0.01 | +2.99% |
| Feb 27, 2026 | Dec 31, 2025 | 0.2248 | 0.2292 | 0.00 | +1.96% |
| Aug 1, 2025 | Jun 30, 2025 | 0.2002 | 0.3027 | +0.10 | +51.20% |
| Mar 3, 2025 | Dec 31, 2024 | 0.1748 | 0.02918 | -0.15 | -83.31% |
| Aug 1, 2024 | Jun 30, 2024 | 0.1403 | -0.07677 | -0.22 | -154.72% |
News
- Melrose Industries Says GKN Aerospace Reaches $125 Million Settlement in Chemicals Case
- Melrose Industries: Clarity On Garden Grove Is Positive, But Uncertainties Remain
- Banks take different views on Melrose after Garden Grove claims programme
- Melrose Industries: Strong Buy Despite A Major New Risk
- Melrose Industries outlines $100 million claims programme as Garden Grove moves towards restart
- Melrose Industries PLC (MLSPF) Q2 2026 Earnings Call Transcript
- Melrose Industries H1 Earnings Call Highlights
- Melrose shares fall 3.5% as Garden Grove incident drives £30m exceptional cost outlook
- Melrose shares fall 3.5% as Garden Grove incident drives £30m exceptional cost outlook
- Futura Medical gets greenlight for stronger product "Eroxon Intense"
Your note
Sign in to keep a note on MLSPF — it syncs with the Stock Master app.